Goshen Heart & Vascular Center was the first in northern Indiana to utilize the newly released Agent Drug-Coated Balloon.
Pictured from left are Michelle Tucker, R.N.; Blair MacPhail, M.D.; Jason Shroff, respiratory therapist; Stephanie Diaz, R.N.; Ashley Ornatowski, R.N.; and Francheska Leal Rivera, respiratory therapist. Photo provided.

News Release

GOSHEN — Goshen Heart & Vascular Center was the first in northern Indiana to conduct a procedure using the newly released Agent Drug-Coated Balloon from Boston Scientific. The technology successfully reopened a coronary artery that had repeatedly clotted despite multiple previous interventions.

“We are committed to bringing the latest advancements in cardiovascular care to our community,” said Randy Christophel, Goshen Health president and chief executive officer. “This new drug-coated balloon represents a significant step forward in treating complex cases of coronary artery disease, and we are proud to offer this high level of care right here in Goshen. Our dedication to excellence ensures that our patients receive the best possible outcomes without needing to travel elsewhere.”

The Agent Drug-Coated Balloon is used to treat coronary artery in-stent restenosis, reopening arteries previously treated with other balloon angioplasty and stents, a key tool in treating patients experiencing complications.

Goshen Heart & Vascular Center is ranked in the top 10 percent of hospitals for heart attack care by the American College of Cardiology and American Heart Association.